These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4808193)

  • 21. Clinical experiences with methadone maintenance in young adults (rehabilitation of heroin addicts with methadone: the public health approach versus the individual perspective).
    Johnson B; Corman AG; Khantzian EJ; Long J
    Proc Natl Conf Methadone Treat; 1973; 1():601-9. PubMed ID: 4808208
    [No Abstract]   [Full Text] [Related]  

  • 22. Alcohol use in youthful methadone-maintained former heroin addicts: liver impairment and treatment outcome.
    Hartman N; Kreek MJ; Ross A; Khuri E; Millman RB; Rodriguez R
    Alcohol Clin Exp Res; 1983; 7(3):316-20. PubMed ID: 6353983
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis B and C prevalence among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Pereira, Colombia.
    Sepúlveda-Arias JC; Isaza C; Vélez JP
    J Infect Dev Ctries; 2014 Sep; 8(9):1228-30. PubMed ID: 25212091
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic hepatitis. Relation of Australia antigens and antitissue antibodies to the histological aspect and evolution. Apropos of 75 cases].
    Thomas M; Gateau P; Nusinovici V; Caroli J
    Med Chir Dig; 1973; 2(6):323-31. PubMed ID: 4792026
    [No Abstract]   [Full Text] [Related]  

  • 25. Methadone maintenance treatment (MMT): a review of historical and clinical issues.
    Joseph H; Stancliff S; Langrod J
    Mt Sinai J Med; 2000; 67(5-6):347-64. PubMed ID: 11064485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What effects does methadone maintenance treatment have on the rehabilitation of heroin addicts?].
    Hermstad R; Johannessen G; Michelsen K
    Tidsskr Nor Laegeforen; 1998 Aug; 118(20):3139-41. PubMed ID: 9760857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple hepatitis attacks with immunothrombocytopenia in a heroin addict.
    Heer M; Pirovino M; Bühler H; Altorfer J; Schmid M; von Felten A
    Hepatogastroenterology; 1983 Feb; 30(1):12-4. PubMed ID: 6832695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alcoholism in drug addicts. Clinical study].
    Rovera GG; Fassino S; Munno D; Scarso G
    Minerva Med; 1980 Oct; 71(41):3011-5. PubMed ID: 7005750
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anatomopathologic discussion of the relations between the non-specific hepatic lesions of Hodgkin's disease and the discovery of Australia antigen].
    Barge J; Degott C; Erlinger S; Potet F
    Pathol Eur; 1973; 8(4):325-32. PubMed ID: 4789363
    [No Abstract]   [Full Text] [Related]  

  • 30. The alterations of immunological reactivity in heroin addicts and their normalization in patients maintained on methadone.
    Zajícová A; Wilczek H; Holán V
    Folia Biol (Praha); 2004; 50(1):24-8. PubMed ID: 15055740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nursing care in ambulatory methadone programs. A comparative literature study between The Netherlands and The United States].
    Loth CA; van de Wijngaart GF
    Verpleegkunde; 1997 Aug; 12(3):150-9. PubMed ID: 9385233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Difference in the behavior of T-lymphocyte populations in heroin and methadone addicts].
    Brugo MA; Guffanti A; Guzzetti S; Pedretti D; Stringhetti M; Confalonieri F
    Boll Ist Sieroter Milan; 1983; 62(6):517-23. PubMed ID: 6234006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differential diagnosis of hepatitis A, B, C, D and E. Clinical, biochemical and viral serologic criteria. 2: Biochemical pathology--serology--hepatitis A].
    Eisenburg J
    Fortschr Med; 1994 Dec; 112(35-36):519-20. PubMed ID: 7843685
    [No Abstract]   [Full Text] [Related]  

  • 34. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
    Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
    Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic abnormalities in heroin addiction.
    Wetli CV; Noto TA; Fernandez-Carol A
    South Med J; 1974 Feb; 67(2):193-7. PubMed ID: 4130051
    [No Abstract]   [Full Text] [Related]  

  • 36. The New York City Methadone Maintenance Treatment Program after two years - an overview.
    Newman RG; Kagen JG
    Proc Natl Conf Methadone Treat; 1973; 1():794-801. PubMed ID: 4808235
    [No Abstract]   [Full Text] [Related]  

  • 37. A study of the incidence of Australia antigen and antibody in nonhuman primates.
    Rivers SL; Keeling M
    Vox Sang; 1970; 19(3):270-2. PubMed ID: 4993778
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of living and residence patterns of former heroin addicts as a result of their participation in a methadone treatment program.
    Ross S
    Proc Natl Conf Methadone Treat; 1973; 1():554-61. PubMed ID: 4808200
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of antibodies to methadone during methadone maintenance treatment of heroin addicts and its possible clinical implications.
    Gamaleya N; Dmitrieva I; Borg S; Ericcson N
    Eur J Pharmacol; 1999 Mar; 369(3):357-64. PubMed ID: 10225375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of a methadone treatment program upon pregnant addicts and their infants.
    Harper RG; Solish GI; Sang E; Purow H
    Proc Natl Conf Methadone Treat; 1973; 2():1133-7. PubMed ID: 4808259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.